Guided Therapeutics Inc (GTHP) stock
GTHPOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$0.16−0.03 (-15.79%)
Close on Oct 19, 2026Market cap $15.45MP/E –Yield –
Guided Therapeutics gross margin
Gross margin is gross profit as a percentage of revenue.
Guided Therapeutics's gross margin for the twelve months ending Jun 30, 2026 was 75.8%. For fiscal 2025 it was 74.4%, against 28.6% the year before. The highest annual figure on record is 140.2% in fiscal 2020.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 74.4% | +45.9 |
| FY2024 | Dec 31, 2024 | 28.6% | −8.2 |
| FY2023 | Dec 31, 2023 | 36.7% | +559.8 |
| FY2022 | Dec 31, 2022 | -523.1% | −547.8 |
| FY2021 | Dec 31, 2021 | 24.7% | −115.5 |
| FY2020 | Dec 31, 2020 | 140.2% | +234.6 |
| FY2019 | Dec 31, 2019 | -94.4% | −38.3 |
| FY2018 | Dec 31, 2018 | -56.1% | +61.1 |
| FY2017 | Dec 31, 2017 | -117.2% | −181.5 |
| FY2015 | Dec 31, 2015 | 64.3% | +268.9 |
| FY2014 | Dec 31, 2014 | -204.6% | −173.9 |
| FY2013 | Dec 31, 2013 | -30.7% | −29.4 |
| FY2012 | Dec 31, 2012 | -1.3% | +0.9 |
| FY2011 | Dec 31, 2011 | -2.3% | −102.3 |
| FY2010 | Dec 31, 2010 | 100.0% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | 77.6% | +11.0 |
| Q3 FY2025 | Sep 30, 2025 | 58.3% | +8.3 |
| Q2 FY2025 | Jun 30, 2025 | 67.5% | +42.5 |
| Q4 FY2024 | Dec 31, 2024 | -200.0% | −259.1 |
| Q1 FY2024 | Mar 31, 2024 | 66.7% | −33.3 |
| Q4 FY2023 | Dec 31, 2023 | 50.0% | −30.0 |
| Q2 FY2023 | Jun 30, 2023 | 25.0% | −55.0 |
| Q1 FY2023 | Mar 31, 2023 | 59.1% | −9.2 |
| Q3 FY2022 | Sep 30, 2022 | 100.0% | +221.1 |
| Q2 FY2022 | Jun 30, 2022 | 80.0% | −20.0 |
| Q1 FY2022 | Mar 31, 2022 | 80.0% | −260.0 |
| Q4 FY2021 | Dec 31, 2021 | 68.3% | −16.1 |
| Q3 FY2021 | Sep 30, 2021 | -121.1% | −196.1 |
| Q2 FY2021 | Jun 30, 2021 | 100.0% | +0.0 |
| Q4 FY2020 | Dec 31, 2020 | 340.0% | +6740.0 |
| Q3 FY2020 | Sep 30, 2020 | 84.4% | −10.0 |
| Q4 FY2019 | Dec 31, 2019 | 75.0% | +179.8 |
| Q3 FY2019 | Sep 30, 2019 | 100.0% | +0.0 |
| Q2 FY2019 | Jun 30, 2019 | -6400.0% | −6487.5 |
| Q1 FY2019 | Mar 31, 2019 | 94.4% | +69.4 |
| Q4 FY2018 | Dec 31, 2018 | -104.8% | +108.3 |
| Q3 FY2018 | Sep 30, 2018 | 100.0% | +293.9 |
| Q2 FY2018 | Jun 30, 2018 | 87.5% | +81.8 |
| Q1 FY2018 | Mar 31, 2018 | 25.0% | +1.2 |
| Q4 FY2017 | Dec 31, 2017 | -213.1% | −223.6 |
| Q3 FY2017 | Sep 30, 2017 | -193.9% | – |
| Q2 FY2017 | Jun 30, 2017 | 5.7% | – |
| Q1 FY2017 | Mar 31, 2017 | 23.8% | – |
| Q3 FY2016 | Sep 30, 2016 | 10.5% | – |
See a number that looks wrong?